PHARMA INTELLIGENCE U.K. LIMITED

PHARMA INTELLIGENCE U.K. LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NamePHARMA INTELLIGENCE U.K. LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 13787459
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of PHARMA INTELLIGENCE U.K. LIMITED?

    • Publishing of newspapers (58130) / Information and communication
    • Publishing of consumer and business journals and periodicals (58142) / Information and communication
    • Other publishing activities (58190) / Information and communication

    Where is PHARMA INTELLIGENCE U.K. LIMITED located?

    Registered Office Address
    3 More London Riverside
    SE1 2AQ London
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for PHARMA INTELLIGENCE U.K. LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2024
    Next Accounts Due OnSep 30, 2025
    Last Accounts
    Last Accounts Made Up ToDec 31, 2023

    What is the status of the latest confirmation statement for PHARMA INTELLIGENCE U.K. LIMITED?

    Last Confirmation Statement Made Up ToDec 04, 2025
    Next Confirmation Statement DueDec 18, 2025
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToDec 04, 2024
    OverdueNo

    What are the latest filings for PHARMA INTELLIGENCE U.K. LIMITED?

    Filings
    DateDescriptionDocumentType

    Full accounts made up to Dec 31, 2023

    51 pagesAA

    Confirmation statement made on Dec 04, 2024 with updates

    4 pagesCS01

    Memorandum and Articles of Association

    25 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10

    Statement of capital following an allotment of shares on Oct 30, 2024

    • Capital: GBP 50,000,002
    • Capital: USD 3.01
    3 pagesSH01

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of alteration of Articles of Association

    RES01

    Termination of appointment of Levine Chris Randiga as a director on Sep 27, 2024

    1 pagesTM01

    Appointment of Mr Jay Nadler as a director on Sep 27, 2024

    2 pagesAP01

    Termination of appointment of Kevin Stephen Morgan as a director on Sep 10, 2024

    1 pagesTM01

    Termination of appointment of Vicky Harris as a director on Sep 06, 2024

    1 pagesTM01

    Termination of appointment of Roberto Simon Rabanal as a director on Jul 31, 2024

    1 pagesTM01

    Full accounts made up to Dec 31, 2022

    46 pagesAA

    Second filing of a statement of capital following an allotment of shares on Jan 04, 2022

    • Capital: GBP 50,000,002
    4 pagesRP04SH01

    legacy

    4 pagesRP04SH01

    legacy

    5 pagesRP04SH01

    legacy

    pagesALLOTCORR

    legacy

    4 pagesRP04SH01

    legacy

    4 pagesRP04SH01

    Confirmation statement made on Dec 04, 2023 with no updates

    3 pagesCS01

    Appointment of Mr Kevin Stephen Morgan as a director on Sep 07, 2023

    2 pagesAP01

    Termination of appointment of Cem Mehmet Baydar as a director on Sep 07, 2023

    1 pagesTM01

    Director's details changed for Ms Vicky Harris on Mar 31, 2023

    2 pagesCH01

    Change of details for Caerus Uk 1 Limited as a person with significant control on Mar 31, 2023

    2 pagesPSC05

    Registered office address changed from Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB England to 3 More London Riverside London SE1 2AQ on Mar 31, 2023

    1 pagesAD01

    Appointment of Mr Cem Mehmet Baydar as a director on Mar 06, 2023

    2 pagesAP01

    Who are the officers of PHARMA INTELLIGENCE U.K. LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    NADLER, Jay
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    United StatesAmericanExecutive327664850001
    INFORMA COSEC LIMITED
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Secretary
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Identification TypeUK Limited Company
    Registration Number3849195
    279172060001
    ADRIAN, Carl Sheldon
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Director
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    United KingdomBritishAccountant134006860001
    BANE, Simon Robert
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Director
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    United KingdomBritishSolicitor180051020003
    BAYDAR, Cem Mehmet
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    EnglandAmericanChief Consulting Officer306347380001
    HARRIS, Vicky
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    EnglandBritishCompany Director296990150001
    HASHEM, Ramsey
    3rd Ave
    New York
    605
    Ny 10158
    United States
    Director
    3rd Ave
    New York
    605
    Ny 10158
    United States
    United StatesAmericanDirector297444280001
    MORGAN, Kevin Stephen
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    EnglandBritishChief Data Operations Officer271511000001
    NADLER, Jay
    King Street
    St. James's
    SW1Y 6QW London
    Almack House 28
    United Kingdom
    Director
    King Street
    St. James's
    SW1Y 6QW London
    Almack House 28
    United Kingdom
    United StatesAmericanCompany Director296990130001
    PERKINS, Nicholas Michael
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Director
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    United KingdomBritishTax Director66598870001
    RANDIGA, Levine Chris
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    United StatesAmericanAccountant306922140001
    SIMON RABANAL, Roberto
    More London Riverside
    SE1 2AQ London
    3
    England
    Director
    More London Riverside
    SE1 2AQ London
    3
    England
    United StatesAmericanChief Financial Officer306348320001

    Who are the persons with significant control of PHARMA INTELLIGENCE U.K. LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Caerus Uk 1 Limited
    More London Riverside
    SE1 2AQ London
    3
    England
    Jun 01, 2022
    More London Riverside
    SE1 2AQ London
    3
    England
    No
    Legal FormPrivate Limited Company
    Country RegisteredUnited Kingdom
    Legal AuthorityEngland & Wales
    Place RegisteredUk Companies House Register
    Registration Number13970414
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Informa Uk Limited
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Dec 07, 2021
    Howick Place
    SW1P 1WG London
    5
    United Kingdom
    Yes
    Legal FormPrivate Company Limited By Shares
    Country RegisteredUnited Kingdom
    Legal AuthorityCompanies Act 2006
    Place RegisteredUk Register Of Companies
    Registration Number01072954
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0